Back to Journals » Clinical Ophthalmology » Volume 5

Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient

Authors Fazelat, Lashkari K

Published 7 April 2011 Volume 2011:5 Pages 439—441

DOI https://doi.org/10.2147/OPTH.S14584

Review by Single anonymous peer review

Peer reviewer comments 3



Ahad Fazelat, Kameran Lashkari
Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA

Abstract: We present a case of diabetic macular edema in a pregnant patient treated with a single intravitreal injection of triamcinolone acetonomide. Initial presentation and serial examinations after treatment included visual acuity, slit-lamp examination, indirect ophthalmoscopy, and optical coherence tomography. Resolution of visual acuity and macular edema were present six weeks after injection and persisted throughout the duration of the pregnancy without further intervention. No adverse outcomes for either mother or fetus were noted. To our knowledge, this is the first report of intravitreal triamcinolone administration in this patient population to be published in the medical literature.

Keywords: triamcinolone, macular edema, diabetes, pregnancy

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.